[1] 孙立军,王虎, 亢建民.脑功能区胶质瘤手术治疗策略进展[J].医学综述,2015,21(13):2431-2434.
[2] 张懋植.成人低级别胶质瘤的治疗进展[J].中国微侵袭神经外科杂志,2006,11(1):1-2.
[3] 张黎军,赵中.脂肪酸结合蛋白与心脑血管病的早期诊断[J].国际脑血管病杂志, 2010.18(2):128-131.
[4] Veerkamp JH, Maatman RG, Prinsen CF. Fatty acid-binding proteins: structural and functional diversity. Biochem Soc Trans. 1992;20(4):801-805.
[5] Münz M, Zeidler R, Gires O. The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett. 2005;225(1):151-157.
[6] Uma RS, Naresh KN, D'Cruz AK, et al. Metastasis of squamous cell carcinoma of the oral tongue is associated with down-regulation of epidermal fatty acid binding protein (E-FABP). Oral Oncol. 2007;43(1): 27-32.
[7] 周玲丽,曹骥,李薇,等.沉默FABP-5基因对人肝癌HepG2细胞的影响[J].世界华人消化杂志,2015,23(2): 179-188.
[8] 喻长法,郑英姿.缺血修饰白蛋白与心脏型脂肪酸结合蛋白在急性心肌梗死早期诊断中的应用价值[J].浙江实用医学,2015,20(2);84-85.
[9] Chmurzyńska A.The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet. 2006;47(1):39-48.
[10] Münz M, Zeidler R, Gires O. The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett. 2005;225(1):151-157.
[11] Thumser AE, Moore JB, Plant NJ. Fatty acid binding proteins: tissue-specific functions in health and disease. Curr Opin Clin Nutr Metab Care. 2014;17(2): 124-129.
[12] Kawamura T, Kanno R, Fujii H, et al. Expression of liver-type fatty-acid-binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma. Pathobiology. 2005;72(5):233-240.
[13] 宋宇,魏志玄.HtrA2在大鼠脑胶质瘤细胞中的表达[J].中国实用神经疾病杂志,2013,16(6):41-43.
[14] Hammamieh R, Chakraborty N, Barmada M, et al. Expression patterns of fatty acid binding proteins in breast cancer cells. J Exp Ther Oncol. 2005;5(2): 133-143.
[15] Armstrong EH, Goswami D, Griffin PR, et al. Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor β/δ (FABP5-PPARβ/δ) signaling pathway. J Biol Chem. 2014;289(21):14941-14954.
[16] Hammamieh R, Chakraborty N, Das R, et al. Molecular impacts of antisense complementary to the liver fatty acid binding protein (FABP) mRNA in DU 145 prostate cancer cells in vitro. J Exp Ther Oncol. 2004;4(3): 195-202.
[17] Levi L, Lobo G, Doud MK, et al. Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis. Cancer Res. 2013;73(15):4770-4780.
[18] 汤参娥,李萃,肖志强,等.人肺鳞癌组织的比较蛋白质组学研究[J].中华肿瘤杂志,2006,28(4):274-279.
[19] 刘倩,王世凤,徐缓,等.CRABPⅡ和E-FABP在非小细胞肺癌中的表达及其意义[J].中国肺癌杂志,2013,16(1): 12-19.
[20] 陈伟志.内皮祖细胞磁性标记及MR示踪在大鼠脑胶质瘤血管生成研究中的应用[J].中国老年学杂志,2013,33(15): 3682-3684.
[21] Masouyé I, Hagens G, Van Kuppevelt TH, et al. Endothelial cells of the human microvasculature express epidermal fatty acid-binding protein. Circ Res. 1997;81(3):297-303.
[22] 史俊林,曹骥,苏建家,等.表皮型脂肪酸结合蛋白在跨种属肝癌组织中的表达[J].中华肝脏病杂志,2012,20(4): 270-274.
[23] Jeong CY, Hah YS, Cho BI, et al. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma. Oncol Rep. 2012;28(4):1283-1292. |